13 Recruiting Alzheimer Disease Phase 3 Clinical Trials
Active phase 3 studies for alzheimer disease enrolling across the USA. Verify eligibility and contact site coordinators.
All Alzheimer Disease studiesPhase 3 Studies for Alzheimer Disease
🔵 Active, Not Recruiting Phase3
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
📍 Gilbert Neurology — Gilbert, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
📍 Parkway Medical Center — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
📍 IMA Clinical Research Phoenix — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
[18F]PI-2620 Phase 3 Histopathological Study
📍 Barrow Neurological Institute — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
📍 Imaging Endpoints — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
📍 Gilbert Neurology Partners/CCT Research — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
📍 Endeavor Health Systems — Evanston, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase3
Epidemiology and Biomarker Study in Alzheimer's Disease
📍 Care Access - Houston — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase3
Biomarker Exploration in Aging, Cognition and Neurodegeneration
📍 University of California, Irvine — Irvine, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
Nabilone for Agitation Blinded Intervention Trial
📍 University of Calgary — Calgary, Alberta
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
📍 Banner Alzheimer's Institute — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
📍 Local Institution - 1227 — Chandler, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
📍 Local Institution - 2609 — Chandler, Arizona
View Study & Checklist ➔